Transplantation-Associated Thrombotic Microangiopathy Risk Stratification: Is There a Window of Opportunity to Improve Outcomes?
Author:
Publisher
Elsevier BV
Subject
Transplantation,Cell Biology,Hematology,Molecular Medicine,Immunology and Allergy
Reference18 articles.
1. Transplant-associated thrombotic microangiopathy in pediatric hematopoietic cell transplant recipients: a practical approach to diagnosis and management;Dvorak;Front Pediatr,2019
2. Clinical and morphological practices in the diagnosis of transplant-associated microangiopathy: a study on behalf of Transplant Complications Working Party of the EBMT;Moiseev;Bone Marrow Transplant,2019
3. A pragmatic multi-institutional approach to understanding transplant-associated thrombotic microangiopathy after stem cell transplant;Dandoy;Blood Adv,2021
4. Diagnostic and risk criteria for HSCT-associated thrombotic microangiopathy: a study in children and young adults;Jodele;Blood,2014
5. Transplant-associated thrombotic microangiopathy: elucidating prevention strategies and identifying high-risk patients;Jodele;Expert Rev Hematol,2021
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Use of Eculizumab in Pediatric Patients with High-Risk Transplantation-Associated Thrombotic Microangiopathy: Outcomes and Risk Factors Associated with Response and Survival. A Retrospective Study on Behalf of the Spanish Group for Hematopoietic Transplantation and Cellular Therapy (GETH-TC);Transplantation and Cellular Therapy;2024-06
2. Age, GVHD prophylaxis, and timing matter in thrombotic microangiopathy after haematopoietic cell transplantation—A secondary CIBMTR analysis;British Journal of Haematology;2024-05-30
3. Neurological involvement in hematopoietic stem cell transplantation-associated thrombotic microangiopathy;Annals of Hematology;2024-05-20
4. D‐dimer and sinusoidal obstructive syndrome‐novel poor prognostic features of thrombotic microangiopathy in children after hematopoietic cellular therapy in a single institution prospective cohort study;American Journal of Hematology;2024-01-02
5. Eculizumab: Inhibiting C5 Earns a High Five in Prospective Pediatric, Multicenter, High-risk Transplant-associated Thrombotic Microangiopathy Study;The Hematologist;2024
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3